Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingda Liu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Gastrointestinal Oncology|September 15, 2025
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironmentMingfang Xu, Yingda Liu, Xunjie Kuang, et al.
Biomolecules & Biomedicine|February 1, 2023
Establishment of predictive nomogram and web-based survival risk calculator for desmoplastic small round cell tumor: A propensity score-adjusted, population-based studySihao Chen, Yu Pu, Yuzhu Jiang, et al.
Scientific Reports|January 4, 2025
Nanobody-based indirect competitive ELISA for the detection of aflatoxin M1 in dairy productsLi Yi, Haiyuan Liu, Yingda Liu, et al.
IEEE Transactions on Neural Networks and Learning Systems|August 30, 2021
Structure-Aware Feature Disentanglement With Knowledge Transfer for Appearance-Changing Place RecognitionCao Qin, Yunzhou Zhang, Yingda Liu, et al.
Scientific Reports|July 2, 2025
Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinomaMingfang Xu, Yu Pu, Yuzhu Jiang, et al.
Iscience|July 26, 2024
Nuclear <i>NME1</i> enhances the malignant behavior of A549 cells and impacts lung adenocarcinoma patient prognosisMingfang Xu, Yingda Liu, Xunjie Kuang, et al.
Journal of Gastrointestinal Oncology|January 16, 2025
High expression of RBM15 is associated with better prognosis in esophageal squamous cell carcinomaYingda Liu, Yu Pu, Xunjie Kuang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Gastrointestinal Oncology|September 15, 2025
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironmentMingfang Xu, Yingda Liu, Xunjie Kuang, et al.
Biomolecules & Biomedicine|February 1, 2023
Establishment of predictive nomogram and web-based survival risk calculator for desmoplastic small round cell tumor: A propensity score-adjusted, population-based studySihao Chen, Yu Pu, Yuzhu Jiang, et al.
Scientific Reports|January 4, 2025
Nanobody-based indirect competitive ELISA for the detection of aflatoxin M1 in dairy productsLi Yi, Haiyuan Liu, Yingda Liu, et al.
IEEE Transactions on Neural Networks and Learning Systems|August 30, 2021
Structure-Aware Feature Disentanglement With Knowledge Transfer for Appearance-Changing Place RecognitionCao Qin, Yunzhou Zhang, Yingda Liu, et al.
Scientific Reports|July 2, 2025
Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinomaMingfang Xu, Yu Pu, Yuzhu Jiang, et al.
Iscience|July 26, 2024
Nuclear <i>NME1</i> enhances the malignant behavior of A549 cells and impacts lung adenocarcinoma patient prognosisMingfang Xu, Yingda Liu, Xunjie Kuang, et al.
Journal of Gastrointestinal Oncology|January 16, 2025
High expression of RBM15 is associated with better prognosis in esophageal squamous cell carcinomaYingda Liu, Yu Pu, Xunjie Kuang, et al.
Pageof 1